Abstract
SIRT7 is an NAD+-dependent protein deacetylase with important roles in ribosome biogenesis and cell proliferation. Previous studies have established that SIRT7 is associated with RNA polymerase I, interacts with pre-ribosomal RNA (rRNA) and promotes rRNA synthesis. Here we show that SIRT7 is also associated with small nucleolar RNP (snoRNPs) that are involved in pre-rRNA processing and rRNA maturation. Knockdown of SIRT7 impairs U3 snoRNA dependent early cleavage steps that are necessary for generation of 18S rRNA. Mechanistically, SIRT7 deacetylates U3-55k, a core component of the U3 snoRNP complex, and reversible acetylation of U3-55k modulates the association of U3-55k with U3 snoRNA. Deacetylation by SIRT7 enhances U3-55k binding to U3 snoRNA, which is a prerequisite for pre-rRNA processing. Under stress conditions, SIRT7 is released from nucleoli, leading to hyperacetylation of U3-55k and attenuation of pre-rRNA processing. The results reveal a multifaceted role of SIRT7 in ribosome biogenesis, regulating both transcription and processing of rRNA.
SIRT7 is a protein deacetylase with important roles in rRNA synthesis, ribosome biogenesis and cell proliferation. Here the authors show a role of SIRT7 in rRNA maturation via deacetylation of U3-55k, a core component of the U3 snoRNP complex.
Ribosome biogenesis is a highly regulated process that requires the coordinated activity of all three nuclear DNA-dependent RNA polymerases (Pol I, II and III) along with more than 200 trans-acting factors, including transcription factors, small nucleolar RNPs (snoRNPs), ribosomal proteins, and proteins that promote processing and modification of ribosomal RNA (rRNA)1,2,3. The initial 47S ribosomal precursor RNA (pre-rRNA) is posttranscriptionally cleaved to form the mature 28S, 18S and 5.8S rRNAs. During the maturation process, the pre-rRNA and its processing intermediates undergo numerous posttranscriptional modifications, which are guided and catalysed by snoRNPs (ref. 4).
In eukaryotes, the U3 snoRNA-containing snoRNP is essential for processing of pre-rRNA (refs 4, 5). U3 snoRNA is associated with four common box C/D core snoRNP proteins, that is, 15.5k, Nop56, Nop58, and fibrillarin and the U3-specific protein U3-55k (refs 4, 6). The 12S U3 snoRNP particle constitutes a subcomplex of the phylogenetically conserved 80S/2.2 MDa small-subunit (SSU) processome, a large ribonucleoprotein complex that assembles on nascent pre-rRNA and is indispensable for ribosome biogenesis7,8,9,10. The yeast SSU processome contains as many as 72 proteins, including endonucleases, RNA helicases, ATPases, GTPases, protein kinases and other regulatory proteins11. The U3 snoRNA was implicated in pre-rRNA processing by chemical cross-linking and mutational studies, showing that regions of complementarity allow base pairing of U3 snoRNA with the 5′-ETS and pre-18S rRNA, thus directing pre-rRNA cleavage12,13,14,15,16. Conditional knockout of the U3 snoRNA genes in yeast abolished pre-rRNA processing at specific sites, leading to accumulation of unprocessed 35S pre-rRNA and loss of mature 18S rRNA (ref. 17).
For many years, research on mammalian pre-rRNA processing lagged behind that on budding yeast, mainly because of the power of yeast genetics. A recent screen in human cells identified 286 proteins involved in pre-rRNA synthesis and pre-rRNA maturation, 74 of them having no yeast homologue2. Among the identified genes was SIRT7, which encodes a member of the sirtuin family of NAD+-dependent deacetylases. Sirtuins constitute a phylogenetically conserved protein family with central roles in the cellular response to oxidative, metabolic and genotoxic stress18,19,20. Sirtuins are regarded as intracellular sensors of the metabolic environment, as the enzymatic activity is dependent on the cosubstrate NAD+ (refs 21, 22). Little is known about SIRT7 function and only a few molecular substrates of SIRT7 have been identified. SIRT7 is enriched in nucleoli, where it facilitates RNA polymerase I (Pol I)-dependent transcription by interacting with the upstream binding factor (UBF; ref. 23) and the Pol I subunit PAF53 (ref. 24). Interaction with and deacetylation of PAF53 by SIRT7 drives ribosomal DNA (rDNA) transcription and ribosome biogenesis, and consequently, cell growth and proliferation24,25. SIRT7 expression correlates with cell growth and proliferation, being abundant in metabolically active cells, and low or even absent in non-proliferating cells25. Consistent with a functional link between SIRT7, ribosome biogenesis and cell proliferation, SIRT7 is overexpressed in several types of tumours26,27,28.
In accord with previous studies showing that pre-rRNA transcription and processing are functionally coupled8,29,30, we report here that SIRT7 plays an essential role not only in rDNA transcription but also in specific cleavage of pre-rRNA. We show that SIRT7 is associated with U3 snoRNPs and promotes pre-rRNA cleavage at the 5′-terminal processing site by deacetylating U3-55k (Rrp9), a core subunit of the U3 snoRNP complex, deacetylation of U3-55k being required for all subsequent processing events. On exposure to hyperosmotic stress, SIRT7 is released from nucleoli, leading to hyperacetylation of U3-55k and processing defects. The results uncover a SIRT7-dependent mechanism that links rDNA transcription to pre-rRNA processing, reinforcing the pivotal role of SIRT7 in ribosome biogenesis, cell metabolism and homeostasis.
Results
SIRT7 is associated with snoRNAs
To characterize the repertoire of nuclear RNAs that are associated with SIRT7, we performed cross-linking and immunoprecipitation (CLIP)-seq, that is, immunoprecipitated Flag-tagged SIRT7 from UV-cross-linked HEK293T cells and sequenced the co-precipitated RNA. Deep sequencing of SIRT7-associated RNAs and subsequent bioinformatic analysis identified pre-rRNA, numerous messenger RNAs (mRNAs) and non-coding RNAs (Supplementary Fig. 1a). Consistent with SIRT7 being associated with Pol I and activating rDNA transcription24, the majority of SIRT7-associated RNA reads (87.8%) covered the entire transcribed region of rDNA, supporting that SIRT7 binds to nascent pre-rRNA (Fig. 1a and Supplementary Fig. 1b,c). About 9.7% of reads mapped to transcripts synthesized by Pol II and 0.8% to RNAs synthesized by Pol III. Among the SIRT7-associated Pol II and Pol III transcripts, RNAs implicated in RNA metabolism were enriched, including mRNAs encoding ribosomal proteins and snoRNAs (Fig. 1b). We identified a total of 43 snoRNAs, comprising all three classes of snoRNA, that is, box C/D, box H/ACA and small Cajal body-specific (sca) RNAs (Fig. 1c and Supplementary Table 1). Two of them, U3 and U13 snoRNA, are transcribed from their own promoter, U3 RNA being the most abundant one (Fig. 1d and Supplementary Fig. 1d). In addition, numerous intron-encoded snoRNAs were associated with SIRT7, including SNORA73A, SNORA73B, SNORA74A, SCARNA6, SCARNA13 and SCARNA10, the distribution of reads at the coding region of these snoRNA being markedly higher than at adjacent genomic regions, indicating that SIRT7 is associated with mature snoRNAs (Supplementary Fig. 2a). To validate that SIRT7 binds to mature U3 snoRNA rather than the U3 snoRNA precursor (pre-U3 snoRNA), we performed reverse transcription–quantitative polymerase chain reaction (RT–qPCR) of U3 snoRNA associated with Flag-tagged SIRT7 using primers covering the 8 nt extension at the 3′ end of pre-U3 snoRNA. This analysis, together with alignment of the U3 snoRNA CLIP-seq reads, revealed that SIRT7 predominantly interacts with mature and not with pre-U3 snoRNA (Supplementary Fig. 1e,f).
To prove that the interaction of SIRT7 with snoRNAs is direct rather than mediated by auxiliary proteins, we repeated the CLIP experiments under native and denaturing conditions, under which only direct protein/RNA interactions are preserved. Analysis of recovered RNA by RT–qPCR confirmed direct binding of SIRT7 to pre-rRNA and to snoRNAs identified by CLIP-seq (Fig. 1e and Supplementary Fig. 2b,d). Moreover, we validated the association of SIRT7 with several snoRNAs identified by CLIP-seq in HEK293T cells that stably or transiently express Flag/HA- or Flag-tagged SIRT7 (Supplementary Fig. 2c–f). Moreover, chromatin immunoprecipitation (ChIP) assays revealed that SIRT7 is associated with rDNA and some snoRNA gene loci, for example, U3 and U13 snoRNA genes, but not with intron-encoded snoRNA genes, for example, U14, SNORA73A, SNORA74A, SCARNA10 and SCARNA13 (Fig. 1f). Together with the observation that expression of U3 snoRNA was decreased by 50% in SIRT7-deficient cells (Supplementary Fig. 2g), this result suggests that SIRT7 affects transcription or stability of U3 snoRNA.
SIRT7 promotes U3 snoRNA-dependent pre-rRNA processing
The finding that SIRT7 is associated with both pre-rRNA and snoRNAs suggests that beyond its function in rDNA transcription SIRT7 may also be involved in snoRNP-dependent processing of pre-rRNA. To test this, RNA was metabolically labelled in control and SIRT7-deficient cells, and pre-rRNA and processing intermediates were analysed by gel electrophoresis and fluorography (Fig. 2a). Consistent with SIRT7 activating Pol I transcription25, depletion of SIRT7 led to roughly 50% reduction in 47/45S pre-rRNA and 28S rRNA. Notably, the level of nascent 18S rRNA was even more decreased, suggesting that SIRT7 plays a role in 18S rRNA processing.
To examine whether SIRT7 promotes U3 snoRNA-dependent cleavage of pre-rRNA within the external transcribed spacer (5′ETS), we performed in vitro processing assays using 32P-labelled RNA covering the first processing site at position +650. After incubation with extracts from mouse L1210 cells, transcripts were cleaved in a time-dependent fashion, yielding shorter RNAs that were cut at the 5′ETS processing site (Fig. 2b and Supplementary Fig. 3a). A control transcript comprising nucleotides from +709 to +1290 was not cleaved, underscoring the requirement of sequences around the 5′-terminal processing site at +650 for specific RNA cleavage. In support of SIRT7 serving a role in pre-rRNA processing, in vitro cleavage of the template RNA was inhibited if extracts were prepared from cells that were treated with nicotinamide (NAM), a competitive inhibitor of sirtuins (Fig. 2c). Conversely, processing activity increased if the reactions were supplemented with NAD+ (Fig. 2d), corroborating that the enzymatic activity of sirtuin(s) is beneficial for 5′-terminal processing of pre-rRNA. To prove that SIRT7 is the NAD+-dependent enzyme that promotes processing, the assays were performed in the absence or presence of recombinant SIRT7. In accord with SIRT7 promoting pre-rRNA processing, exogenous SIRT7, but not the enzymatically inactive mutant SIRT7/H187Y, enhanced specific cleavage of the template RNA (Fig. 2e and Supplementary Fig. 3b). Moreover, 5′ETS processing was attenuated in extracts from SIRT7-depleted cells, processing being restored after addition of wild-type SIRT7 but not the enzymatically inactive mutant SIRT7/H187Y (Fig. 2f and Supplementary Fig. 3c). Depletion of U3 snoRNA from the cell extract by antisense oligonucleotides abolished cleavage at position +650 regardless of whether SIRT7 was added or not, confirming that in vitro processing was dependent on U3 snoRNP (Fig. 2g and Supplementary Fig. 3d). Together, these data demonstrate that both U3 snoRNA and SIRT7 are required for 5′ETS pre-rRNA cleavage, the initial step in 18S rRNA processing.
SIRT7 counteracts PCAF-dependent acetylation of U3-55k
Mammalian U3 snoRNPs are composed of the five core subunits U3-55k, NOP56, NOP58, fibrillarin and 15.5k (ref. 4). As the catalytic activity of SIRT7 is required for processing in vitro, SIRT7-dependent deacetylation of any core subunit might be required for efficient processing. Previous acetylome studies revealed that the U3 snoRNP-specific protein U3-55k is acetylated in the N-terminal domain31. We therefore reasoned that reversible acetylation of this subunit might regulate U3 snoRNA-dependent pre-rRNA processing. To test this, we monitored acetylation of U3-55k protein in cells treated with trichostatin A (TSA), an inhibitor of class I/II HDACs, or with NAM, which specifically inhibits sirtuins. In the absence of any inhibitor or on treatment with TSA, acetylation was barely detectable on western blots using an antibody that recognizes acetylated proteins. However, acetylation was markedly increased if cells were treated with NAM (Fig. 3a) or in cells overexpressing PCAF, suggesting that PCAF is the acetyltransferase that acetylates U3-55k (Supplementary Fig. 4a). In support of this view, short interfering RNA (siRNA)-mediated depletion of PCAF abolished acetylation of U3-55k regardless whether or not cells were treated with NAM (Fig. 3b).
To investigate whether SIRT7 or another nuclear sirtuin deacetylates U3-55k, we monitored the association of U3-55k with SIRT1, SIRT6 and SIRT7. The immunoprecipitation experiments in Fig. 3c,d show that endogenous or Flag-U3-55k was associated with endogenous and ectopic SIRT7, but not with SIRT1 or SIRT6. No binding of U3-55k to SIRT7 was observed if SIRT7 was affinity-purified under denaturing conditions (Supplementary Fig. 4b). In addition, U3-55k acetylation was compromised in cells overexpressing green fluorescent protein-human sirtuin 7 (GFP-SIRT7), but not in cells overexpressing SIRT1, underscoring that SIRT7 targets U3-55k for deacetylation (Fig. 3e). In support of this view, depletion of SIRT7 by short hairpin RNAs (shRNAs) or genetic knockout of SIRT7 led to hyperacetylation of U3-55k without affecting expression of U3-55k (Fig. 3f and Supplementary Fig. 4c,d). Significantly, recombinant SIRT7 efficiently deacetylated U3-55k in vitro, reinforcing that PCAF-mediated acetylation of U3-55k is counteracted by SIRT7 (Fig. 3g and Supplementary Fig. 4e).
Deacetylation of U3-55k promotes pre-rRNA processing
To investigate whether reversible acetylation of U3-55k affects its interaction with U3 snoRNA, we monitored the association of U3-55k with U3 snoRNA by CLIP assays. These experiments revealed that binding of U3-55k to U3 snoRNA inversely correlated with U3-55k acetylation, the interaction with U3 snoRNA being decreased if cells were treated with NAM to inhibit SIRT7 activity (Fig. 4a, left). Consistent with acetylation impairing the interaction between U3-55k and U3 snoRNA, the association of U3-55k with U3 snoRNA was decreased in SIRT7 knockout cells (Fig. 4a, right). These findings emphasize that deacetylation of U3-55k by SIRT7 is required for efficient binding of U3-55k to U3 snoRNA.
To decipher the functional significance of U3-55k acetylation, we replaced two lysine residues (K12, K25) within the N-terminal domain of U3-55k that were reported to be acetylated31 by either arginine or glutamine, and monitored the impact of wild-type and mutant U3-55k on pre-rRNA processing. Overexpression of PCAF increased acetylation of wild-type U3-55k but did not augment acetylation of the K12/K25 mutants, supporting that PCAF acetylates K12 and K25 (Supplementary Fig. 5a). Fluorescence microscopy revealed similar nucleolar/nuclear distribution of wild-type U3-55k and the mutants that mimick the non-acetylated (2KR) or acetylated (2KQ) state of U3-55k, indicating that acetylation of K12/25 did not alter the cellular localization of U3-55k (Supplementary Fig. 5b). Significantly, acetylation of wild-type U3-55k was markedly increased in SIRT7-deficient cells, whereas acetylation of mutant U3-55k remained low, regardless of whether SIRT7 was depleted or not (Fig. 4b).
If deacetylation of U3-55k by SIRT7 is required for proper 18S rRNA processing, depletion of either U3-55k or SIRT7 should cause similar defects in pre-rRNA processing. Indeed, knockdown of U3-55k or knockout of SIRT7 impaired the formation of 18S rRNA processing intermediates 21S and 18SE RNA (Fig. 4c and Supplementary Fig. 5c). This result is in accord with studies showing that U3-55k-dependent cleavage at sites A0 and 1 is required for 18S rRNA processing10. The finding that cells depleted of U3-55k or SIRT7 exhibit similar processing defects was further corroborated by metabolic labelling of nascent RNA. The amount of labelled 18S rRNA was markedly reduced in U3-55k-deficient cells, resembling the processing defects observed in SIRT7 knockdown cells (Fig. 4d and Supplementary Fig. 5d). Notably, wild type and the acetylation-deficient mutant of U3-55k (2KR) were capable to rescue the processing defect, whereas the acetylation-mimicking K12/25Q (2KQ) mutant did not restore processing (Fig. 4d and Supplementary Fig. 5e,f). This result is supported by CLIP assays showing that binding of mutant U3-55k/2KQ to U3 snoRNA was compromised, while the acetylation-deficient K12/25R (2KR) mutant bound with similar efficiency as wild-type U3-55k (Fig. 4e and Supplementary Fig. 5g). Likewise, in vitro pull-down experiments showed reduced binding of U3 snoRNA to U3-55k/2KQ or to hyperacetylated U3-55k as compared with wild-type U3-55k or the acetylation-deficient mutant U3-55k/2KR (Fig. 4f and Supplementary Fig. 5h).
It is well established that the 15.5k protein interacts with its cognate RNAs via a kink-turn motif. The U3 snoRNA-specific kink-turn motif is comprised in box B/C (refs 32, 33, 34). It was proposed that binding of 15.5k to the B/C motif is essential for recruitment of U3-55k and for the subsequent nucleation of the SSU processome. However, it remained controversial whether U3-55k interacts with U3 RNA independent of the 15.5k protein34,35. To address this issue, we performed northwestern analyses, incubating membrane-bound U3-55k with radioactive-labelled U3 BC RNA. These experiments revealed that U3-55k and the acetylation-deficient mutant U3-55k/2KR retained U3 snoRNA (U3 BC), while RNA binding of the acetylation-mimicking mutant 2KQ was compromised (Fig. 4g). In contrast, SIRT7 bound with similar efficiency to wild-type and mutant U3 snoRNA (ref. 34) confirming the specificity of U3-55k binding to U3 snoRNA. In complementary pull-down experiments, we tested the interaction of bead-bound GFP-U3-55k with U3 snoRNA. For this, immobilized U3-55k protein (or TIF-IA as a negative control) was incubated with radiolabelled wild-type or mutant U3 RNA, in the absence or presence of increasing amounts of GST-15.5k protein, and bound RNA was visualized by gel electrophoresis and PhosphorImaging. In accord with previous reports34,35, this assay revealed that binding of U3-55k to U3 snoRNA is markedly stimulated by the 15.5k protein (Fig. 4h and Supplementary Fig. 5i). Again, U3-55k did not bind to mutant U3 (mutB) RNA, regardless whether or not 15.5k was present. Together, these results demonstrate that acetylation impairs the interaction of U3-55k with U3 snoRNA, which in turn is a prerequisite for the production of 18S rRNA. Apparently, SIRT7 keeps U3-55k in the deacetylated state in proliferating cells with high rRNA synthetic activity, allowing association with U3 snoRNA, processome formation and pre-rRNA cleavage.
Acetylation of U3-55k impairs rRNA processing under stress
To examine the functional relevance of SIRT7-dependent regulation of pre-rRNA processing, we compared levels of pre-rRNA and processing intermediates in cells grown in normal medium and in cells exposed to hypertonic conditions. Northern blot analysis revealed that the 47S precursor was barely detectable on hypertonic stress. The level of 47S pre-rRNA was restored on reversal to normo-osmotic conditions, implying that stress-induced transcriptional repression is reversible (Fig. 5a and Supplementary Fig. 6a). Notably, in hypertonic cells the precursors of 18S rRNA, that is, 21S and 18SE rRNA, were barely detectable, indicating that exposure to hypertonic stress impaired the production of mature 18S rRNA (Fig. 5a).
To decipher the molecular mechanism underlying stress-dependent inhibition of pre-rRNA processing, we monitored U3-55k acetylation under different stress conditions that inhibit nucleolar transcription such as hypertonic stress, treatment with actinomycin D or treatment with 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). Both physiological and drug-induced stress caused robust hyperacetylation of U3-55k, whereas acetylation of mutant K12/25R (2KR) was not affected (Fig. 5b and Supplementary Fig. 6b). Stress-induced hyperacetylation had little effect on the nucleolar localization of U3-55k, whereas both endogenous and ectopic SIRT7 translocated from nucleoli to the nucleoplasm (Fig. 5c and Supplementary Fig. 6c). These results imply that translocation into the nucleoplasm separates SIRT7 from nucleolar U3-55k, which in turn leads to hyperacetylation of U3-55k and processing defects.
To examine whether stress-induced redistribution of SIRT7 from the nucleolus into the nucleoplasm correlates with compromised pre-rRNA processing, we monitored 18S rRNA processing intermediates in parental U2OS cells and in U2OS cells which stably express GFP-SIRT7. Overall, 47S rRNA levels and relevant processing intermediates were elevated in U2OS/GFP-SIRT7 cells compared with parental U2OS cells (Fig. 5d). On exposure to hypertonic stress, pre-rRNA synthesis and processing were suppressed in both cell lines. However, attenuation of processing was less pronounced in cells expressing GFP-SIRT7. This is probably due to the fact that a fraction of ectopic GFP-SIRT7 remained in nucleoli (Supplementary Fig. 6c), which alleviates processing defects. This result underscores the impact of SIRT7 on pre-rRNA processing, release from nucleoli under stress conditions leading to hyperacetylation of U3-55k and impaired pre-rRNA cleavage.
As U3 snoRNPs are required for 18S rRNA processing and acetylation of U3-55k compromises its interaction with U3 snoRNA, the association of U3-55k with U3 snoRNA should be decreased in cells exposed to hypertonicity. Indeed, CLIP experiments revealed a significant decrease in U3-55k-associated U3 snoRNA in stressed cells, while the overall level of U3 snoRNA remained unaffected (Fig. 5e and Supplementary Fig. 6d). Consistent with SIRT7 being released from nucleoli on transcriptional or energetic stress24, binding of SIRT7 to snoRNAs and pre-rRNA was no longer detected under hyperosmotic conditions, supporting that the interaction between SIRT7 and U3 snoRNA was abolished (Fig. 5f). Notably, overexpression of the acetylation-deficient mutant U3-55k/2KR, but not the acetylation-mimicking mutant U3-55k/2KQ, rescued the stress-induced processing defect, emphasizing the functional importance of hypoacetylated U3-55k in pre-rRNA processing (Fig. 5g).
Discussion
Recent studies have linked expression of SIRT7 to cell proliferation and oncogenic activity, connecting SIRT7-dependent regulation of ribosome biogenesis with checkpoints controlling cell cycle progression, tumorigenesis and formation of metastatic phenotypes26,27,36,37,38,39. Despite this important functional link, the enzymatic activity, the molecular targets and physiological functions of SIRT7 are poorly defined. Similar to other sirtuins, SIRT7 depletion did not globally change the acetylation levels of nucleolar and nuclear proteomes36,40, indicating that sirtuins exhibit a weak or substrate-specific deacetylase activity. SIRT7 was shown to target lysine 18 of histone H3 (H3K18), hypoacetylation of H3K18 compromising transcription of target genes36,39. No measurable deacetylase activity of SIRT7 has been detected on other histone peptide substrates in vitro, supporting that SIRT7 functions as a highly specific deacetylase. In vivo, SIRT7 has been shown to deacetylate GABPβ1, a key regulator of mitochondrial functions, deacetylation of GABPβ1 promoting mitochondrial gene expression41. Moreover, SIRT7 deacetylates the Pol I subunit PAF53, which enhances recruitment of Pol I to the rDNA promoter and activates transcription24.
In this study, we have identified the nucleolar protein U3-55k as a novel substrate of SIRT7, deacetylation of U3-55k being required for 18S rRNA maturation. U3-55k is associated with U3 snoRNA, the core of the SSU processome, which promotes 5′ETS processing4,7,8,11,42,43. Consistent with pre-rRNA transcription and processing being intertwined, the SSU processome binds to the 5′ ETS of pre-rRNA enabling endonucleolytic cleavage of the primary transcript 650 nucleotides downstream of the 5′ end of pre-rRNA (refs 4, 9, 11, 16). The SSU processome was proposed to act as a pre-rRNA chaperone enabling pre-18S rRNA folding and processing through base pairing of U3 snoRNA with pre-rRNA (refs 11, 14). These findings indicate that the sequence and/or structural elements within the 5′ETS contribute to the accuracy or even the order of processing steps. U3 snoRNA-dependent cleavage of pre-rRNA has been observed in several organisms, including humans and mice4,16,29,44, indicating that this mechanism is conserved among eukaryotes.
Although the importance of snoRNAs in pre-rRNA processing and posttranscriptional 2′-O-methylation and pseudouridylation of the rRNAs has been known for decades, our understanding of the molecular mechanisms by which mammalian pre-rRNA processing is regulated is very limited, owing mainly to the lack of in vitro systems that respond to regulatory factors. Processing of the 5′ ETS was first linked to snoRNAs in vertebrates when a crude in vitro system was shown to faithfully cleave the 5′ ETS in a U3 snoRNA-dependent fashion5. Using this system, we found that cleavage of a template RNA bearing the first processing site of mouse pre-rRNA was compromised if SIRT7 activity was inhibited by NAM, or if extracts from SIRT7-depleted cells were used in the processing reactions. Supplementation with NAD+ and ectopic SIRT7 stimulated RNA cleavage, whereas an enzymatically inactive SIRT7 mutant failed to rescue processing activity. Moreover, in SIRT7-deficient cells the level of metabolically labelled 18S rRNA was markedly reduced, reinforcing the functional importance of SIRT7-dependent deacetylation of component(s) of the U3 snoRNP in early pre-rRNA processing events.
Our results reveal that SIRT7 regulates pre-rRNA processing by deacetylation of U3-55k, a U3 snoRNA-associated protein that is not present in other box C/D snoRNPs. Consistent with acetylation affecting protein functions, we found that acetylation by PCAF impairs binding of U3-55k to U3 snoRNA, the association of U3-55k with U3 snoRNA being required for processing. Deacetylation by SIRT7, on the other hand, facilitates the interaction of U3-55k with U3 snoRNA, thus promoting pre-rRNA processing. The intimate link between SIRT7 activity and acetylation-dependent U3-55k function is underscored by the finding that knockdown of U3-55k led to the same defects in pre-rRNA processing as those observed on knockout of SIRT7. Overexpression of wild-type U3-55k but not the acetylation-mimicking mutant 2KQ overcame the processing defects, emphasizing that SIRT7 and U3-55k are functionally connected.
The link between U3-55k acetylation and its removal by SIRT7 not only highlights the central role of SIRT7 in ribosome biogenesis but also points to an active role of SIRT7 as a pro-survival adaptor molecule in conditions of cellular stress24,45,46,47. Previous studies have demonstrated that SIRT7 is released from nucleoli in response to transcriptional or metabolic stress, leading to hyperacetylation of the Pol I-associated factor PAF53 and downregulation of rDNA transcription24. The present study shows that translocation of SIRT7 on short exposure to hyperosmotic stress leads also to hyperacetylation of U3-55k and hence inhibition of pre-rRNA processing. Nucleolar retention of overexpressed SIRT7 under hypertonic stress attenuates processing defects corroborating the stress tolerance conferred by SIRT7 to the cells. Hyperosmolarity impaired the generation of 21S and 18SE pre-rRNA, whereas 30S pre-RNA was hardly affected. Interestingly, RNAi-mediated knockdown of U3-55k or other U3 snoRNA-specific proteins, such as NOP56, NOP58 or fibrillarin, led to the same processing defects as hyperosmolarity10, supporting that SIRT7 regulates key factors involved in rDNA transcription and pre-rRNA processing. Thus SIRT7 plays a dual function in ribosome biogenesis, coupling rDNA transcription and pre-rRNA processing by deacetylating PAF53 and U3-55k. Nucleolar release of SIRT7 in response to environmental or metabolic cues disrupts this crosstalk, enhancing acetylation of PAF53 and U3-55k, which in turn inhibits Pol I transcription and processing. Given that SIRT7 interacts with many RNAs that are transcribed by Pol II, it is tempting to speculate that SIRT7 function is not restricted to rDNA but might also prompt other genes to promote cellular survival and stress resistance, thus regulating a variety of important cellular processes.
Methods
Transfections and cell treatments
U2OS and HEK293T cells (ATCC) cultured in DMEM/10% foetal bovine serum were transfected with expression vectors encoding epitope-tagged proteins using the calcium phosphate precipitation technique or Fugene6 (Life Technologies). Cells were harvested 36–48 h post transfection. To generate clonal cell lines that stably express FLAG/HA- or GFP-tagged SIRT7, cells were selected in the presence of G418 (750 μg ml−1). siRNAs against SIRT7 (hSIRT7 ON-TARGETplus SMARTpool), PCAF (hPCAF ON-TARGETplus SMARTpool), or non-targeting control siRNAs were from Dharmacon (ThermoFisher Scientific) and siRNAs against U3-55k (Supplementary Table 2) from Life Technologies. After reverse transfection with Lipofectamine 2000 or RNAiMax (Invitrogen), cells were harvested after 48–60 h. pLKO.1 plasmids containing mouse SIRT7-specific shRNAs were co-transfected with Pax-2 and VSV-G plasmids into HEK293T cells for production of Lentiviruses. Lentivirus-mediated depletion of SIRT7 was performed in L1210 cells (ATCC) cultured in DMEM/10% horse serum. To induce hyperosmotic stress, cells were cultured for 60–90 min in medium supplemented with 200 mM NaCl. Transcriptional and metabolic stress was induced by treatment with actinomycin D (100 ng ml−1, 4 h) and AICAR (0.5-1 mM, 12 h), respectively.
Plasmids and antibodies
Plasmids encoding hSIRT7, sh-hSIRT7, Flag-PCAF, CBP-HA and p300-HA have been described25,48. To generate GFP- and Flag-tagged U3-55k, cDNA encoding human U3-55k (NCBI reference sequence: NM_004704.4) was inserted into pEGFP-C (Clontech) or pCMV-Tag2 (Stratagene). Point mutations converting K12 and K25 of U3-55k into arginine (2KR) and glutamine (2KQ) were introduced by PCR. To generate FLAG/HA-tagged hSIRT7, the sequence of the Flag/HA-tag was amplified by PCR and cloned into the plasmid pCMV-hSIRT7. Plasmids encoding mSIRT7-specific shRNAs were generated by cloning the corresponding sequences into pLKO.1. Oligos used for plasmid construction and site-directed mutagenesis are listed in Supplementary Table 3. Polyclonal antibodies against SIRT7 were generated in rabbits and purified as described25. Briefly, rabbits were immunized with purified GST-SIRT7(1-86) expressed in E. coli, and the antiserum was purified using GST-SIRT7(1-86) coupled to Affigel (BioRad). Commercial antibodies include anti-acetylated lysine (AcK, Cell Signaling, 9441), anti-nucleolin (Santa Cruz, sc-13057), anti-U3-55k (Abcam, ab56460), anti-Flag (Sigma, F3165), anti-actin (Abcam, ab8227), anti-tubulin (Sigma, clone B-5-1-2, T6074), anti-GFP (Abcam, ab290), anti-PCAF (Santa Cruz, sc-8999) and anti-UBF (Santa Cruz, sc-13125). Anti-HA and anti-GST antibodies were a gift from E. Kremmer (Helmholtz Center Munich). The anti-Flag M2 Affinity Gel (Sigma, F1804) was used for precipitation of Flag-tagged proteins and the GFP-Trap (Chromotek, gta) for purification of GFP-tagged proteins.
Immunoprecipitation of cross-linked RNA
RNA-immunoprecipitation from UV-cross-linked HEK293T cells expressing Flag-SIRT7 or Flag-U3-55k was essentially done as follows24. Nuclei from UV-irradiated (254 nm, 0.15 J cm−2) cells were lysed in 20 mM Tris-HCl pH 8.0, 200 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate in the presence of protease inhibitors (Roche Complete). After sonication, lysates were precleared with protein G Sepharose (1 h, 4 °C), adjusted to 0.05% SDS and 0.25% sodium deoxycholate, and protein-RNA complexes were immunoprecipitated overnight at 4 °C using anti-Flag M2 beads (Sigma) or protein G Sepharose (GE Healthcare) coated with mouse IgG (Dianova) as control. Beads were washed three times in immunoprecipitation (IP) buffer and twice in IP buffer containing 400 mM KCl. After elution with the Flag peptide (20 μg per 100 μl, 4 h) and proteinase K digestion (30 min, 55 °C), RNA was isolated with TRIzol (ThermoFisher Scientific), incubated with DNase I (Sigma), reverse transcribed using random hexamers and M-MLV reverse transcriptase (Applied Biosystems) and cDNA was amplified by qPCR.
For affinity-purification of SIRT7-V5/His under native conditions, nuclei from UV-cross-linked cells (254 nm, 0.15 J cm−2) were lysed in buffer containing 50 mM Tris-HCl pH 7.6, 200 mM NaCl, 0.1% NP-40, 5 mM ß-mercaptoethanol and protease inhibitors (Roche Complete). After binding of SIRT7-V5/His to Ni-NTA-agarose (Qiagen), beads were washed with lysis buffer containing 500 mM NaCl. Protein-RNA complexes were eluted with 500 mM imidazole, 50 mM Tris-HCl pH 7.6, 50 mM NaCl, 0.1% NP-40, 5 mM ß-mercaptoethanol and digested with proteinase K (0.2 mg ml−1, 30 min, 55 °C). RNA was isolated with TRIzol, treated with DNase I (Sigma), transcribed into cDNA using random hexamers and M-MLV reverse transcriptase (Life Technologies) and quantified by qPCR using SYBR Green I Master mix (Roche) and Roche Lightcycler 480. The gene-specific primers are listed in Supplementary Table 3. For affinity-purification under denaturing conditions, lysis of nuclei and binding was performed in 50 mM Tris-HCl pH 7.6, 300 mM NaCl, 0.1% NP-40, 5 mM ß-mercaptoethanol, 10 mM imidazole and 6 M guanidinium-HCl. After washing with denaturing buffer and two washes with 50 mM Tris-HCl pH 7.6, 10 mM MgCl2, 0.5% NP-40, 10 mM ß-mercaptoethanol protein-RNA complexes were eluted and RNA was monitored by RT–qPCR.
CLIP-Seq and bioinformatic analysis
The CLIP-seq experiments were performed in biological duplicates. Co-immunoprecipitated RNA from anti-Flag-SIRT7 and IgG control immunoprecipitations was purified with TRIZOL, and treated with DNase I. The RNA-seq libraries were created using the NEBNext Ultra RNA Library Prep kit for Illumina (E7530) with NEBNext Multiplex Oligos for Illumina (E7300). 50 cycles of sequencing were performed on the Illumina HiSeq 2000 Instrument. cDNA libraries from total RNA were used as Input. The reads were mapped to human hs37 reference genome (including human rRNA sequence) using Tophat2 with default parameters. The reads with mapping quality >0 were used for analysis. The RPKM (reads per kilobase per million mapped reads) values were calculated for all genes with annotation in Gencode V17 including mRNA and snoRNAs. The SIRT7 reads distributions on genes transcribed by different polymerases (Pol I, II and III) were calculated and normalized to the total number of mapped reads. To identify snoRNAs encoded in introns of host genes, snoRNAs coordinates were retrieved from Gencode V17 annotations. The coverage plots were produced with R Gviz package. Gene ontology (GO) annotations were done using DAVID v6.7.
Generation of SIRT7 knockout cell lines by CRISPR-Cas9
Four single guide RNAs (sgRNAs 1-4) that target different regions within exon 1 of the human SIRT7 gene were selected from previously published genome-wide human sgRNA libraries49,50. The sequences are given in Supplementary Table 3. Oligos corresponding to the sgRNAs were cloned into the lentiCRISPRv1 vector containing the SpCas9 gene and a puromycin selection marker gene50,51. HEK293T cells were transfected with either of the sgRNAs and selected with puromycin (750 ng ml−1) 24 h post transfection. Single clones were retrieved after 7 days of puromycin selection, expanded and analysed for abrogation of SIRT7 expression by western blotting. Manifestation of the SIRT7 mutations was verified by PCR and sequencing.
Metabolic labelling of nascent RNA
0.5 × 106 U2OS or HEK293T cells were cultured for 3 h in growth medium containing 5 μCi 3H-uridine (PerkinElmer). Total RNA (2 μg) was separated on a denaturing 1% agarose gel in 20 mM MOPS, pH 7.0, 5 mM sodium acetate and 1 mM EDTA, transferred to Hybond-N+ nylon membranes (GE Healthcare), and labelled RNA was visualized by fluorography using EN3HANCE (PerkinElmer).
Chromatin immunoprecipitation
ChIP experiments were performed as follows25. In brief, nuclei were isolated from HEK293T or U2OS cells fixed with 1% formaldehyde (10 min, room temperature) and quenched with 0.125 M glycine. After sonication (Bioruptor, Diagenode) to yield 250–500 bp fragments chromatin was diluted fivefold with IP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.0 and 167 mM NaCl), precleared with protein A and G Sepharose (GE Healthcare) in the presence of 200 μg ml−1 of sonicated E. coli DNA, and incubated overnight with the respective antibodies. Protein-DNA complexes were captured on protein A and G Sepharose followed by washes in low-salt buffer (150 mM NaCl, 50 mM Tris-HCl pH 8.0, 5 mM MgCl2, 1% Triton X-100), high-salt buffer containing 500 mM NaCl, LiCl buffer (250 mM LiCl, 10 mM Tris-HCl pH 8.0, 5 mM EDTA, 0.5% Na-deoxycholate and 0.5% Triton X-100) and Tris EDTA buffer. After reversal of the cross-link, DNA was purified and amplified by qPCR. Precipitated DNA was calculated as the percentage of input DNA. Primers are listed in the Supplementary Table 3.
In vitro processing assay
Processing of pre-rRNA in vitro was performed as follows5. Extract proteins (60–80 μg) from L1210 cells were incubated with 20 fmoles of 32P-labelled synthetic transcripts in 20 mM Hepes pH 7.9, 2 mM MgCl2, 0.14 mM EDTA, 1.5 mM ATP, 120 mM KCl, 2 mM DTT and 9% (v/v) glycerol. The reaction was terminated by the addition of an equal volume of 2% SDS, 12.5 mM EDTA, 0.4 mg ml−1 glycogen and 0.4 mg ml−1 proteinase K. After incubation for 30 min at 42 °C, radiolabelled RNA was analysed by electrophoresis on 6% polyacrylamide/TBE gels and PhosphorImaging (Fujifilm).
Co-immunoprecipitation
Cells were lysed in 20 mM Tris-HCl pH 7.9, 0.1% NP-40, 150 mM KCl, 5 mM MgCl2, 0.2 mM EDTA, 10% (v/v) glycerol and Complete protease inhibitors (Roche). Cleared lysates were incubated overnight with the respective antibodies or control IgGs, precipitated proteins were eluted with the corresponding epitope peptides or with SDS sample buffer and visualized on western blots.
Western blotting
Western blotting was performed according to standard procedures. Antibodies used were anti-SIRT7 (1:2000), anti-HA (1:1,000), anti-Flag (1:1,000), anti-actin (1:5,000), anti-tubulin (1:5,000), anti-acetyl-lysine (1:500), anti-PCAF (1:500), anti-U3-55k (1:1,000), anti-GFP (1:10,000), anti-nucleolin (1:1,000), anti-GST (1:2,000) and anti-rabbit or anti-mouse secondary antibodies conjugated to HRP (1:20,000, Dianova 111-035-144, and 115-035-062). Signals were visualized using LAS-3000 (Fujifilm) and ImageGauge. Uncropped blots are shown in the Supplementary Fig. 7.
In vitro deacetylation
HEK293T cells co-expressing GFP-U3-55k and Flag-PCAF were harvested and lysed in buffer AM-400 (400 mM KCl, 20 mM Tris-HCl pH 8.0, 0.2 mM EDTA pH 8.0, 5 mM MgCl2 and 10% (v/v) glycerol) supplemented with 0.1% NP-40, Roche Complete protease inhibitors, 500 nM TSA, and 10 mM NAM, and GFP-U3-55k was purified using GFP-Trap. Flag-SIRT7 was immunopurified from HEK293T cells. In brief, cells were lysed in buffer AM-300 (300 mM KCl, 20 mM Tris-HCl pH 7.9, 5 mM MgCl2, 0.2 mM EDTA, 10% glycerol and 0.5 mM DTT) supplemented with 0.1% NP-40, protease inhibitors (Roche Complete), and HDAC inhibitors (500 nM TSA, 5 mM sodium butyrate and 10 mM NAM). Lysates were incubated overnight at 4 °C with M2 anti-Flag beads (Sigma). After washing, tagged proteins were eluted in buffer AM-300 supplemented with 0.1% NP-40 and Flag peptide (20 μg per 100 μl). For in vitro deacetylation, 0.8–1 μg of pre-acetylated bead-bound-GFP-U3-55k was incubated for 1 h at 30 °C with 0.8 μg of Flag-SIRT7 in 10 mM Tris-HCl pH 8.0, 4 mM MgCl2, 0.2 mM DTT, 10% glycerol in the presence or absence of 2 mM NAD+. Acetylation of U3-55k was monitored on immunoblots using anti-pan-AcK antibodies.
Immunofluorescence
Cells grown on poly-L-lysine coated coverslips (ThermoFisher Scientific) were fixed for 10 min with 2.4% paraformaldehyde, permeabilized for 30 s with ice-cold methanol and incubated overnight at 4 °C with anti-UBF (Santa Cruz cat. no. sc-13125, 1:600). For visualization of SIRT7, cells were permeabilized for 10 min with PBS containing 0.5% Triton X-100 and incubated overnight with purified anti-SIRT7 antibody (1:200). Alexa Fluor555-labelled secondary antibody (Life Technologies, 1:400) was used in indirect immunofluorescence and nuclei were counterstained with 5 μg ml−1 of Hoechst 33342 (Sigma). Images were processed using NIS-Elements BR 3.10 and ImageJ software.
RNA analysis
RNA was isolated with TRIzol Reagent (Invitrogen), transcribed into cDNA using random primers (Roche), and analysed by real-time PCR (Roche, LightCycler480) using primers listed in Supplementary Table 3. Alternatively, 47S pre-rRNA was assayed on northern blots by hybridization with a 32P-labelled antisense RNA probe complementary to the first 155 nucleotides of pre-rRNA25. Processing intermediates were monitored by hybridization to a 32P-labelled ITS1 oligonucleotide (Supplementary Table 3). The membrane was pre-hybridized in 6xSSC, 5xDenhardt's, 0.5% SDS and 100 μg ml−1 transfer RNA for 1 h at 45 °C, followed by hybridization in the same buffer supplemented with the 32P-oligo probe for 16 h at 45 °C. After washing at room temperature in 2xSSC, 0.1% SDS (twice for 10 min) and in 1xSSC, 0.1% SDS (10 min) radioactive signals were visualized by PhosphorImaging.
RNA pull-down experiments
Immobilized GFP-tagged U3-55k was incubated for 3 h at 4 °C with radiolabelled U3 snoRNA or mutB RNA (ref. 34) in buffer AM-200 (200 mM KCl, 20 mM Tris-HCl pH 8.0, 0.2 mM EDTA, 5 mM MgCl2, 10% (v/v) glycerol, 0.1% NP-40, 1 mM EGTA and 10 mM ß-mercaptoethanol). After stringent washing, bound RNA was extracted, subjected to gel electrophoresis and visualized by PhosphorImaging.
Northwestern blot
Northwestern assays were performed as described24. Briefly, purified proteins were separated by SDS-polyacrylamide electrophoresis, transferred to nitrocellulose membranes (GE Healthcare) and proteins were re-natured in 10 mM Tris-HCl pH 6.8, 25 mM NaCl, 1 mM EDTA, 0.04% BSA and 0.04% NP-40 at 4 °C (16 h) and incubated for 2 h at room temperature in the same buffer supplemented with 6.6 nM of 32P-labelled in vitro transcribed U3 snoRNA. After washing in buffer containing 150 mM NaCl, 50 mM Tris-HCl pH 8.0 and 0.1% Tween-20, bound RNA was detected by PhosphorImaging.
Statistics and quantitative analyses
The values in the graphs show means of three independent experiments with error bars representing s.d. SPSS 16.0 software was used for statistical analysis. Analyses of variance were performed using analysis of variance with Bonferroni's test. The significance level was set at P<0.05 or P<0.01. Quantification of western blot signals and radioactive signals was performed using ImageJ and Image Gauge software, respectively.
Additional information
Accession codes: The CLIP-seq data generated in this study have been deposited into Gene Expression Omnibus data base hosted at the NCBI under the accession code GSE76578.
How to cite this article: Chen, S. et al. SIRT7-dependent deacetylation of the U3-55k protein controls pre-rRNA processing. Nat. Commun. 7:10734 doi: 10.1038/ncomms10734 (2016).
Supplementary Material
Acknowledgments
We thank Jeanette Seiler for excellent technical assistance, Anja Rippert and Steeve Boulant (DKFZ, Heidelberg) for help with lentiviruses, Weijun Feng (DKFZ) for reagents, Elisabeth Kremmer (Helmholtz Center Munich) for providing anti-HA and anti-GST antibodies, and David Ibberson (Bioquant Heidelberg) for high throughput sequencing. We are grateful to Ger Pruijn (Radboud University Nijmegen) for providing plasmids encoding U3 snoRNAs and Nicholas Watkins (Newcastle University) for plasmid encoding GST-15.5k. This work has been funded by the DFG (SFB1036), CellNetworks (EcTop Survey 2014) and the Baden-Württemberg Stiftung.
Footnotes
Author contributions R.V. and I.G. conceived the project and S.C., R.V. and I.G. designed the experiments. S.C., M.F.B., A.I. and R.V. performed experiments and analysed data, B.H. and L.W. carried out bioinformatic analyses. All authors contributed to discussions about interpretation of the data and to manuscript review.
References
- Henras A. K. et al. The post-transcriptional steps of eukaryotic ribosome biogenesis. Cell. Mol. Life Sci. 65, 2334–2359 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tafforeau L. et al. The complexity of human ribosome biogenesis revealed by systematic nucleolar screening of Pre-rRNA processing factors. Mol. Cell 51, 539–551 (2013). [DOI] [PubMed] [Google Scholar]
- Lafontaine D. L. J. Noncoding RNAs in eukaryotic ribosome biogenesis and function. Nat. Struct. Mol. Biol. 22, 11–19 (2015). [DOI] [PubMed] [Google Scholar]
- Watkins N. J. & Bohnsack M. T. The box C/D and H/ACA snoRNPs: key players in the modification, processing, and the dynamic folding of ribosomal RNA. Wiley Interdiscip. Rev. RNA 3, 397–414 (2012). [DOI] [PubMed] [Google Scholar]
- Kass S., Tyc K., Steitz J. A. & Sollner-Webb B. The U3 small nucleolar ribonucleoprotein functions in the first step of preribosomal RNA processing. Cell 60, 897–908 (1990). [DOI] [PubMed] [Google Scholar]
- Lübben B., Marshallsay C., Rottmann N. & Lührmann R. Isolation of U3 snoRNP from CHO cells: a novel 55 kDa protein binds to the central part of U3 snoRNA. Nucleic Acids Res. 21, 5377–5385 (1993). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dragon F. et al. A large nucleolar U3 ribonucleoprotein required for 18S ribosomal RNA biogenesis. Nature 417, 967–970 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gallagher J. E. et al. RNA polymerase I transcription and pre-rRNA processing are linked by specific SSU processome components. Genes Dev. 18, 2506–2517 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Granneman S. & Baserga S. J. Crosstalk in gene expression: coupling and co-regulation of rDNA transcription, pre-ribosome assembly and pre-rRNA processing. Curr. Opin. Cell Biol. 17, 281–286 (2005). [DOI] [PubMed] [Google Scholar]
- Sloan K. E., Bohnsack M. T., Schneider C. & Watkins N. J. The roles of SSU processome components and surveillance factors in the initial processing of human ribosomal RNA. RNA 20, 540–550 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Phipps K. R., Charette J. M. & Baserga S. J. The small subunit processome in ribosome biogenesis – progress and prospects. Wiley Interdiscip. Rev. RNA 2, 1–21 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beltrame M. & Tollervey D. Identification and functional analysis of two U3 binding sites on yeast pre-ribosomal RNA. EMBO J. 11, 1531–1542 (1992). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borovjagin A. V. & Gerbi S. A. The spacing between functional Cis-elements of U3 snoRNA is critical for rRNA processing. J. Mol. Biol. 300, 57–74 (2000). [DOI] [PubMed] [Google Scholar]
- Dutca L. M., Gallagher J. E. & Baserga S. J. The initial U3 snoRNA:pre-rRNA base pairing interaction required for pre-18S rRNA folding revealed by in vivo chemical probing. Nucleic Acids Res. 39, 5164–5180 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kudla G., Granneman S., Hahn D., Beggs J. D. & Tollervey D. Cross-linking, ligation, and sequencing of hybrids reveals RNA-RNA interactions in yeast. Proc. Natl Acad. Sci. USA 108, 10010–10015 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mullineux S. T. & Lafontaine D. L. Mapping of cleavage sites on mammalian pre-rRNAs: where do we stand? Biochimie 94, 1521–1532 (2012). [DOI] [PubMed] [Google Scholar]
- Hughes J. M. & Ares M. Jr Depletion of U3 small nucleolar RNA inhibits cleavage in the 5′ external transcribed spacer of yeast pre-ribosomal RNA and impairs formation of 18S ribosomal RNA. EMBO J. 10, 4231–4239 (1991). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haigis M. C. & Sinclair D. A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5, 253–295 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Houtkooper R. H., Pirinen E. & Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225–238 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chang H. C. & Guarente L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol. Metab. 25, 138–145 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Houtkooper R. H., Canto C., Wanders R. J. & Auwerx J. The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr. Rev. 31, 194–223 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Imai S. & Guarente L. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol. Sci. 31, 212–220 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grob A. et al. Involvement of SIRT7 in resumption of rDNA transcription at the exit from mitosis. J. Cell Sci. 122, 489–498 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen S. et al. Repression of RNA polymerase I upon stress is caused by inhibition of RNA-dependent deacetylation of PAF53 by SIRT7. Mol. Cell 52, 303–313 (2013). [DOI] [PubMed] [Google Scholar]
- Ford E. et al. Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20, 1075–1080 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ashraf N. et al. Altered sirtuin expression is associated with node-positive breast cancer. Br. J. Cancer 95, 1056–1061 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Geng Q., Peng H., Chen F., Luo R. & Li R. High expression of Sirt7 served as a predictor of adverse outcome in breast cancer. Int. J. Clin. Exp. Pathol. 8, 1938–1945 (2015). [PMC free article] [PubMed] [Google Scholar]
- Zhang S. et al. Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a. Sci. Rep. 5, 9787 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- Prieto J. L. & McStay B. Recruitment of factors linking transcription and processing of pre-rRNA to NOR chromatin is UBF-dependent and occurs independent of transcription in human cells. Genes Dev. 21, 2041–2054 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kos M. & Tollervey D. Yeast pre-rRNA processing and modification occur cotranscriptionally. Mol. Cell 37, 809–820 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choudhary C. et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834–840 (2009). [DOI] [PubMed] [Google Scholar]
- Watkins N. J. et al. Assembly and maturation of the U3 snoRNP in the nucleoplasm in a large dynamic multiprotein complex. Mol. Cell 16, 789–798 (2004). [DOI] [PubMed] [Google Scholar]
- Shultz A., Nottrott S., Watkins N. J. & Lührmann R. Protein-protein and protein-RNA contacts both contribute to the 15.5k-mediated assembly of the U4/U6 snRNP and the box C/D snoRNPs. Mol. Cell. Biol. 26, 5146–5154 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Granneman S. et al. The hU3-55k protein requires 15.5k binding to the box B/C motif as well as flanking RNA elements for its association with the U3 small nucleolar RNA in vitro. J. Biol. Chem. 277, 48490–48500 (2002). [DOI] [PubMed] [Google Scholar]
- Zhang L., Lin J. & Ye K. Structural and functional analysis of the U3 snoRNA binding protein Rrp9. RNA 19, 701–711 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barber M. F. et al. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487, 114–118 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paredes S., Villanova L. & Chua K. F. Molecular pathways: emerging roles of mammalian Sirtuin SIRT7 in cancer. Clin. Cancer Res. 20, 1741–1746 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yu H. et al. Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer. Clin. Cancer Res. 20, 3434–3445 (2014). [DOI] [PubMed] [Google Scholar]
- Malik S. et al. SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors. Sci. Rep. 5, 9841 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsai Y. C., Greco T. M. & Cristea I. M. Sirtuin 7 plays a role in ribosome biogenesis and protein synthesis. Mol. Cell. Proteomics 13, 73–83 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ryu D. et al. A SIRT7-dependent acetylation switch of GABPß1 controls mitochondrial function. Cell Metab. 20, 856–869 (2014). [DOI] [PubMed] [Google Scholar]
- Grandi P. et al. 90S pre-ribosomes include the 35S pre-rRNA, the U3 snoRNP, and the 40S subunit processing factors but predominantly lack 60S synthesis factors. Mol. Cell 10, 105–115 (2002). [DOI] [PubMed] [Google Scholar]
- Knox A. A. et al. A weak C' box renders U3 snoRNA levels dependent on hU3-55k binding. Mol. Cell. Biol. 31, 2404–2412 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kent T., Lapik Y. R. & Pestov D. G. The 5′ external transcribed spacer in mouse ribosomal RNA contains two cleavage sites. RNA 15, 14–20 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shin J. et al. SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease. Cell Rep. 5, 654–665 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hubbi M. E., Hu H., Kshitiz, Gilkes D. M. & Semenza G. L. Sirtuin-7 inhibits the activity of hypoxia-inducible factors. J. Biol. Chem. 288, 20768–20775 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kiran S., Oddi V. & Ramakrishna G. Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response. Exp. Cell Res. 331, 123–141 (2015). [DOI] [PubMed] [Google Scholar]
- Muth V., Nadaud S., Grummt I. & Voit R. Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription. EMBO J. 20, 1353–1362 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang T., Wei J. J., Sabatini D. M. & Lander E. S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80–84 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shalem O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84–87 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanjana N. E., Shalem O. & Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.